Therapeutic agents encapsulated in liposomes have been successfully applied to model systems as diverse as enzyme replacement therapy (1-3), heavy metal detoxification (4), and cancer chemotherapy (5). The increasing interest in the potential of liposomes as carriers for pharmacologically active agents is demonstrated by several recent reviews (6-9). Answers to the pervading problem of how to bring functional molecules into contact with a specific target in a controlled fashion must be sought through systematic investigations of optimal liposome size, structure, and membrane composition. Throughout these investigations, it is essential to know whether the administered liposomes remain intact. Indium-ill entrapped in liposomes is ideally suited for this purpose because radioisotope tracer methods can be used to determine the physical location of '111n, and the structural integrity of the liposomes can be monitored in vivo by gamma-ray perturbed angular correlation (PAC) studies.
ABSTRACT The structural integrity of unilamellar vesicles has been studied in vitro and in vivo by use of gamma-ray perturbed angular correlation techniques. These studies utilize li1In3+ weakly bound to the chelator nitrilotriacetic acid as a probe to monitor the percentage of intact vesicles. When complexes of Illn3+ and nitrilotriacetic acid is encapsulated in vesicles, lllIn3+ exhibits a fast tumbling rate. Upon alteration of the membrane, ll1n3+ is released from the liposomes and becomes bound to macromolecules, consequently exhibiting a decrease in IlllIn3+ tumbling rate. The in vitro experiments show that the present technique is capable of determining quantitatively the percentage of material released from the vesicues upon the addition of serum or Triton X-100 to vesicles. The percentage of vesicles remaining intact in vivo can also be monitored continuously by the present technique. In mice, the half-life of dipalmitoyl phosphatidylcholine-cholesterol vesicles after intraperitonea injection was estimated to be [10] [11] [12] [13] hr. The present study suggests that the vesicles remain intact in various tissues for extended periods, thereby allowing a slow release of the encapsulated material at those sites.
Therapeutic agents encapsulated in liposomes have been successfully applied to model systems as diverse as enzyme replacement therapy (1-3), heavy metal detoxification (4) , and cancer chemotherapy (5) . The increasing interest in the potential of liposomes as carriers for pharmacologically active agents is demonstrated by several recent reviews (6) (7) (8) (9) . Answers to the pervading problem of how to bring functional molecules into contact with a specific target in a controlled fashion must be sought through systematic investigations of optimal liposome size, structure, and membrane composition. Throughout these investigations, it is essential to know whether the administered liposomes remain intact. Indium-ill entrapped in liposomes is ideally suited for this purpose because radioisotope tracer methods can be used to determine the physical location of '111n, and the structural integrity of the liposomes can be monitored in vivo by gamma-ray perturbed angular correlation (PAC) studies.
The PAC technique as used in these studies monitors changes in the rotational correlation time of the "'1In ion (10) (11) (12) . Two gamma rays are emitted in cascade from the radioactive "'IIn nucleus and are detected by a coincidence spectrometer. The coincidence counting rate depends strongly on the angle between the directions of propagation of the gamma rays. This angular correlation may be perturbed by interaction of the radioactive nucleus with its environment. Thus, PAC studies can provide information concerning changes in the tumbling rate of I'1'n ions bound to molecules with different rotational correlation times.
The strategy adopted for determining the intactness of li- Carrier-free "'InCl3 in 0.05 M HCl/0.9% NaCl was obtained from Medi + Physics, Glendale, CA. The "'IInCl3 was purified from the saline and other contaminants by chromatography on Bio-Rad AG 1X-8 (0.7 X 10 cm column) in 0.1 M HCL. The fractions were collected in Nalgene beakers and taken to dryness under heat lamps. lllIn3+ was complexed to NTA by the addition of 0.9% NaCI/5 mM sodium phosphate, pH 7.4 (Pi/ NaCI) containing 1 mM NTA to the "'InCl3.
Preparation of Vesicles. Unilamellar vesicles were prepared from DPPC and DPPC-cholesterol, 2:1, (mol/mol). DPPC vesicles were prepared by addition of 1.0 ml of a solution containing 1-2 mCi of 11In3+ in 1 mM NTA/Pi/NaCl to 54 ,tmol of solid DPPC in a small conical tube. For the DPPC-cholesterol vesicles, the DPPC (27 ,umol) and cholesterol (13.5 ,tmol) were dissolved in chloroform and dried to a thin film at 420 under a stream of nitrogen; then 0.5 ml of a solution containing 1-2 mCi of "11In3+ in 1 mM NTA/Pi/NaCl was added. The tubes were shaken briefly by a Vortex mixer and placed into a Branson sonicator with a titanium microtip. Sonication was carried out for 15 min at high power in a glycerol bath. The vesicle suspension was then centrifuged for 15 min at 300 X g, 25°, for 30 min to remove any titanium fragments and highly aggregated material. The effect of serum on the permeability of vesicles containing lllIn3+ was investigated by measuring the change in (G22(oo)) with time after the addition of fresh rabbit serum to the vesicle preparations. After extended periods of incubation at 250 in the presence of serum, these vesicle preparations were chromatographed on Sepharose 4B to confirm the extent of leakage of lllIn3+ from the vesicles. When complete release of the entrapped NTA-lllIn3+ complex was desired, the vesicles were disrupted by the addition of chloroform or Triton X-100, or both.
In Vivo Studies. BALB/c mice from Jackson Laboratories (Bar Harbor, ME) and C57BL/6 mice bred at California In- In vivo PAC studies, using 16 ± 2 ,uCi of "'1In3+ per mouse, were accomplished by placing the live mouse in the barrel of a modified plastic syringe centered in the spectrometer (13) . After measurement of the (G22(oo)) of the mouse for periods of up to 3 hr, the animal was returned to its cage. Additional measurements were performed at varying intervals during the 3 days after injection of vesicles containing lllIn3+.
The tissue distribution of lllIn3+ after intraperitoneal administration of lllIn3+-vesicles (0.1 ml of vesicle suspension containing 3.5 ,4Ci of entrapped NTA-111In3+ per mouse) was examined. After varying lengths of time, the mice were killed by cervical dislocation followed immediately by decapitation. Organs and tissues were washed with 0.9% NaCl, blotted, and weighed. The distribution of injected radioactivity was determined by assaying the tissue samples in a well-type gamma-ray spectrometer.
RESULTS
In Vitro Experiments. Measurement of (G22(co)) of the sequentially emitted 173-and 247-keV gamma rays of "'1In provides a convenient method of estimating the rotational correlation time of the molecule to which the "'IIn ion is bound (12) . Values of (G22(cx)) for llIn3+ in various environments are shown in Table 1 This is supported by the results of the gel filtration studies (Fig.  2) . DPPC-cholesterol vesicle preparations were shown by electron microscopy and analytical ultracentrifugation to be heterogeneous in size with a mean diameter of 650 A. These preparations contained less than 10% multilamellar liposomes.
The structural stability of our vesicle preparations was examined by dialysis of representative preparations of DPPC vesicles and DPPC-cholesterol vesicles. These measurements indicated leakages of 3.0% and 2.2%, respectively, in 24 hr at 25°, thus showing that they are of comparable stability in physiological salt solutions. Addition of rabbit serum, however, affected the permeability of the two types of vesicles to different extents (Table 1; Fig. 2 ). The percentage of 111In3+ bound to serum proteins can be calculated by using the following expression (10):
(G22(oo)) = x(G22(0z))f + (1 -X)(G22(a'))b [1] in which x is the mole fraction of lllIn3+ remaining entrapped within the vesicles, (G22(cx))f is the time integrated perturbation factor of NTA-"'In3+ inside the vesicles, and (G22(o))b is the factor of II1In3+ bound to protein. By using Eq. 1 and the data in Table 1 Fig. 4 . The curves represent different strains of mice and separate preparations of DPPC-cholesterol vesicles. However, both give similar patterns for vesicle destruction, with 50% disruption occuring in 10-13 hr. Based on counting rates, it was determined that the lllIn3+ was being excreted from the mice at approximately 5% of the injected dose every 24 hr.
The PAC measurements give us an indication of the overall integrity of the injected vesicles. Further information regarding their fate was obtained from tissue radioactivity distribution studies. The data in Fig. 5 indicate that the intraperitoneally injected DPPC-cholesterol vesicles were rapidly removed from the injection site via abdominal lymphatics with subsequent drainage into the venous system and distribution throughout the mouse by way of the circulation. The amount of l1lIn3+ in the blood increased rapidly such that 50% of the recovered 111In3+ (42% of injected dose) was in the blood at 2.5 hr after injection. Similar blood radioactivity levels have been observed after intraperitoneal injection of other sonicated liposomes (14) . Coincident with the increase in lllIn3+ in the blood, a decrease in the llIIn3+ recovered with the skin was observed. At 2.5 hr only 16% of the recovered radioactivity (14% of the injected dose) was found in the liver. At the later time points, (e.g., 29.5 hr), almost complete removal of lllIn3+ from the blood had occurred and the liver had become the major site for lllIn3+ recovery. Less than 0.3% of the 111In3+ was detected in the brain at any time point.
Comparison of PAC data (Fig. 4 ) with information at early time points of the tissue distribution studies indicates that little destruction of the DPPC-cholesterol vesicles occurred during uptake of the liposomes from the site of injection. Two lines of evidence suggest that the vesicles remain intact in the bloodstream. The first is based on the nearly complete removal of 1 1In3+ from the blood within 24 hr. If vesicle destruction had occurred in the circulation, the lllIn3+ would have bound to serum proteins, mainly transferrin (13, 15) , and consequently be retained in the blood for extended periods of time. Furthermore, the PAC measurements show that -80% of the vesicles remained intact 3 hr after vesicle administration.
The amount of radioactivity found in the liver increased steadily during the first 17 hr, as expected, after administration of small vesicles (16) . This suggests that the DPPC-cholesterol vesicles were cleared from the blood and taken up by the liver. It is noteworthy that PAC measurements showed -35% of the vesicles remaining intact 17 hr after injection (Fig. 4A ) but only 6% of the radioactivity was in the blood at that time according to tissue radioactivity distribution. This suggests that there were intact vesicles lodged in body tissues. The contents of these vesicles were slowly released as indicated by the further decrease in the percentage of intact vesicles remaining in the mice (Fig. 4) and the constant radioactivity levels in various tissues (Fig. 5) .
Our results indicate that encapsulation in DPPC-cholesterol vesicles affords considerable protection of the lllIn3+ from interaction with tissues and biological fluids. This was further substantiated by examining the fate of 111In3+ in 1 mM NTA/ Pi/NaCl injected intraperitoneally into mice. Immediately after the injection, the (G22(o)) fell to 0.21 ± 0.02 and remained steady over the next 2.5 hr. Tissue examinations on mice sacrificed 2.6 hr after intraperitoneal injection of NTA/"'1In3+ showed 0.2% of the 111In3+ in the blood and 0.4% in the skin. More than 93% of the lllIn3+ was recovered with the intestine The C57BL/6 mice used were 53 days old and had a mean weight of 17.3 g; blood volume was assumed to be 1.3 ml. X, Skin; 0, blood; 0, liver; *, intestine; A, kidney; o, spleen; A, lung. and was not removed by washing the tissue with 0.9% NaCl, indicating binding of the 1"In3+ to tissue at or near the site of injection. No significant excretion of lllIn3+ was detected in the 24 hr after administration of NTA/"'1In3+ to other mice.
DISCUSSION
The versatility of liposomes as carriers of pharmacologically active agents has become increasingly apparent. Entrapment of therapeutic materials in various types of lipid vesicles can in principle not only afford protection for the material but also allow the rate and route of its uptake to be altered. Attempts to determine the fate of administered liposomes by classical radioactive tracer methods have been complicated by the difficulty in distinguishing entrapped radioactivity from that released from the liposomes. Alternative methods for studying the fate of liposomes have been sought. McDougall et al. (17) used electron paramagnetic resonance spectra to characterize the integrity of unilamellar vesicles, containing the spin label tempocholine, before injection and after their recovery in mouse blood. More recently, Weinstein et al. (18) utilized the self-quenching fluorescent properties of the entrapped dye 6-carboxyfluorescein to distinguish between material still remaining in vesicles and that released intracellularly in in vitro cell suspension systems.
The approach developed in this paper for establishing the structural integrity of vesicles by monitoring the molecular motion of 1I1In3+ has broad applicability in vitro as well as in vivo. In this method, lllIn3+ in the presence of a suitable chelator is added to the aqueous phase during liposome preparation. The ability to assess membrane integrity would not be affected by the method used for formation of liposomes, the nature of the membrane constituents, or the presence of other entrapped components.
The in vitro experiments using entrapped llIn3+ clearly show that the PAC technique is capable of detecting alterations in membrane structure occurring upon the addition of serum to vesicles. These findings are in agreement with a previous report (19) indicating that some liposomes that are stable to leakage of captured ions in physiological salt solutions become Proc. Nati. Acad. Sci. USA 74 (1977) more leaky in the presence of fresh serum. The greater stability of DPPC-cholesterol vesicles in the presence of serum was anticipated based on previous reports that inclusion of cholesterol in the bilayer results in a decrease in premeability of the liposomes (20) (21) (22) . This points out the usefulness of PAC for rapid initial in vitro testing of liposomes of varying compositions to assess their structural stability. This technique could screen liposomes and eliminate from in vivo testing programs those preparations that would undergo unsatisfactory rates of destruction upon entering the bloodstream.
More important, however, is the usefulness of the procedures described in this paper for application to in vivo experiments. We have shown that by using PAC it is possible to monitor continuously the percentage of vesicles remaining intact in vivo. This is a parameter not readily determinable by other techniques. In addition, the PAC measurements suggest that vesicles can remain intact in various tissues for extended periods and, thereby, can slowly release the encapsulated material at those sites. Our data do not allow determination of rates of vesicle destruction in specific organs or tissues. However, the present method can in principle be adapted to investigate the integrity of vesicles in any specific area of the body by using lead shielding to block out other areas. The data could also be combined with tissue distributions obtained by using wholebody scintillation scanners to yield more complete kinetic information. Alternatively, information on vesicle destruction at specific sites can be obtained in future studies through injection of vesicle preparations containing sufficiently high levels of entrapped lllIn3+ such that, upon sacrifice of the animals, PAC measurements could be made on isolated organs and tissues.
